Aspro Raveen Parboosing

Raveen Parboosing is a South African clinical virologist and academic based in KwaZulu-Natal, widely recognised for research on HIV and hepatitis B virus in high-burden settings. Affiliated with the University of KwaZulu-Natal and collaborating with the National Health Laboratory Service, his work integrates laboratory diagnostics with public health surveillance to inform treatment policy and epidemic control in Southern Africa.

His scholarship centres on HIV drug resistance, viral load dynamics, and the impact of antiretroviral rollout, particularly dolutegravir-based regimens. Through large-scale geospatial and temporal analyses, he has mapped patterns of viraemia and resistance, highlighting hotspots and guiding data-driven interventions. Additional contributions address HBV/HIV coinfection, persistent HBV viraemia, and molecular mechanisms underpinning treatment failure.

Parboosing’s research also spans translational and experimental studies, including aptamer-based HIV latency reversal, targeted nanoparticle delivery to CD4+ T cells, cancer cell apoptosis models, and SARS-CoV-2 seroepidemiology and variant severity. This breadth reflects strengths in molecular virology, genomics, and diagnostic innovation, with sustained impact on infectious disease management and laboratory medicine in resource-limited settings.